Cord Blood T Cells Fight Solid Tumors | Science News

Science News Today | 2 Min News | The Daily News Now! · Sep 11, 2026 · 1m

Scientists at UCLA have unlocked a revolutionary cancer treatment by engineering T cells from donated cord blood — creating an “off-the-shelf” therapy that outperforms current methods. In mice, a single dose halted tumors, extended survival, and avoided dangerous side effects. Unlike traditional therapies that require custom patient-specific cells, these pre-made cells can be stored and rapidly deployed, slashing costs and wait times. The breakthrough uses immature stem cells from cord blood, engineered to target cancer with precision while avoiding harmful natural receptors. Even better, the…